Teva Pharmaceutical Industries Limited Stock price TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 5,782B | Sales 2025 * | 16.28B 5,938B | Capitalization | 14.93B 5,445B |
---|---|---|---|---|---|
Net income 2024 * | 420M 153B | Net income 2025 * | 743M 271B | EV / Sales 2024 * | 1.86 x |
Net Debt 2024 * | 14.62B 5,333B | Net Debt 2025 * | 12.12B 4,419B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
14.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.57% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-2.92% | 203B | |
-3.72% | 158B |